Fenebrutinib (GDC-0853)
CAS: 1434048-34-6
Ref. 3D-JHC04834
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
Fenebrutinib is a long-acting monoclonal antibody that inhibits the activity of stem cell factor. It binds to the stem cell factor, preventing it from binding to its receptor and causing platelets to aggregate. Fenebrutinib has been shown to be safe and effective in preclinical studies for heparin-induced thrombocytopenia and related conditions, including autoimmune diseases such as rheumatoid arthritis. Fenebrutinib is being developed as a treatment for cancer, inflammatory bowel disease, and other autoimmune disorders. This drug is selective for c-KIT (a type of enzyme called kinase) but does not affect other kinases such as JAK1 or JAK2.
Chemical properties
Technical inquiry about: 3D-JHC04834 Fenebrutinib (GDC-0853)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
